Merck nears $10bn deal for respiratory drugmaker Verona
US pharma giant seeks to expand footprint beyond cancer treatment as its biggest product nears patent cliff
Full Article
Merck nears $10bn deal for respiratory drugmaker Verona
FT.com
0 shares
1 views